Literature DB >> 9751229

The relationship between smoking and triglyceride-rich lipoproteins is modulated by genetic variation in the glycoprotein IIIa gene.

M Sentí1, C Aubó, M Bosch.   

Abstract

In the last year, several studies have reported conflicting results concerning an association between the PI(A2) allele of the PI(A1/A2) polymorphism of platelet glycoprotein IIIa and the risk of myocardial infarction. In the present study, we analyzed the hypothesis of whether glycoprotein IIIa genotypes have any association with lipids and lipoproteins as classical cardiovascular risk factors. Smoking, associated with changes in triglyceride-rich lipoprotein (TRL) concentrations and with both hypercoagulability and reduced fibrinolysis, was also analyzed as an environmental factor. Blood samples were obtained from 170 subjects (83 men and 87 women; mean age, 57 years; SD 15) recruited by random sampling from the census of Girona, Spain. Subjects were classified as current smokers (n=41) and nonsmokers or exsmokers (n=129). Whereas no differences were found in lipid and lipoprotein concentrations between smokers and nonsmokers in subjects with the PI(A1/A1) genotype, smokers with the PI(A1/A2) or PI(A2/A2) genotypes showed significantly higher triglyceride and very-low-density lipoprotein (VLDL) triglyceride concentrations than nonsmokers or exsmokers with the same genotypes. Similarly, the VLDL triglyceride/HDL cholesterol ratio was significantly different in subjects with the PI(A1/A2) or PI(A2/A2) genotypes stratified according to smoking status. Further analysis revealed a significant interaction between smoking and genotype when those homozygous for the allele PI(A1) were compared with one or two PI(A2) alleles for the three lipidic parameters. The observed effects appear to show links between smoking, triglyceride metabolism, and a glycoprotein involved in platelet aggregation. It is likely that the pI(A) polymorphism is in linkage disequilibrium with other functional mutations that might influence triglyceride metabolism under some environmental factors such as smoking. This finding may provide a new perspective in the complex relationship between glycoprotein IIIa gene, environment, and their interactions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9751229     DOI: 10.1016/s0026-0495(98)90274-8

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  4 in total

Review 1.  Platelet PlA2 polymorphism and thromboembolic events: from inherited risk to pharmacogenetics.

Authors:  P J Goldschmidt-Clermont; C M Roos; G E Cooke
Journal:  J Thromb Thrombolysis       Date:  1999-08       Impact factor: 2.300

2.  A genome-wide screen for interactions reveals a new locus on 4p15 modifying the effect of waist-to-hip ratio on total cholesterol.

Authors:  Ida Surakka; Aaron Isaacs; Lennart C Karssen; Pirkka-Pekka P Laurila; Rita P S Middelberg; Emmi Tikkanen; Janina S Ried; Claudia Lamina; Massimo Mangino; Wilmar Igl; Jouke-Jan Hottenga; Vasiliki Lagou; Pim van der Harst; Irene Mateo Leach; Tõnu Esko; Zoltán Kutalik; Nicholas W Wainwright; Maksim V Struchalin; Antti-Pekka Sarin; Antti J Kangas; Jorma S Viikari; Markus Perola; Taina Rantanen; Ann-Kristin Petersen; Pasi Soininen; Asa Johansson; Nicole Soranzo; Andrew C Heath; Theodore Papamarkou; Inga Prokopenko; Anke Tönjes; Florian Kronenberg; Angela Döring; Fernando Rivadeneira; Grant W Montgomery; John B Whitfield; Mika Kähönen; Terho Lehtimäki; Nelson B Freimer; Gonneke Willemsen; Eco J C de Geus; Aarno Palotie; Manj S Sandhu; Dawn M Waterworth; Andres Metspalu; Michael Stumvoll; André G Uitterlinden; Antti Jula; Gerjan Navis; Cisca Wijmenga; Bruce H R Wolffenbuttel; Marja-Riitta Taskinen; Mika Ala-Korpela; Jaakko Kaprio; Kirsten O Kyvik; Dorret I Boomsma; Nancy L Pedersen; Ulf Gyllensten; James F Wilson; Igor Rudan; Harry Campbell; Peter P Pramstaller; Tim D Spector; Jacqueline C M Witteman; Johan G Eriksson; Veikko Salomaa; Ben A Oostra; Olli T Raitakari; H-Erich Wichmann; Christian Gieger; Marjo-Riitta Järvelin; Nicholas G Martin; Albert Hofman; Mark I McCarthy; Leena Peltonen; Cornelia M van Duijn; Yurii S Aulchenko; Samuli Ripatti
Journal:  PLoS Genet       Date:  2011-10-20       Impact factor: 5.917

3.  The PlA1/A2 polymorphism of glycoprotein IIIa as a risk factor for myocardial infarction: a meta-analysis.

Authors:  Christopher N Floyd; Agnesa Mustafa; Albert Ferro
Journal:  PLoS One       Date:  2014-07-02       Impact factor: 3.240

4.  Integrin Beta-3 Gene Polymorphism and Risk for Myocardial Infarction in Premature Coronary Disease.

Authors:  Mehrdad Sheikhvatan; Mohammad Ali Boroumand; Mehrdad Behmanesh; Shayan Ziaee; Sara Cheraghee
Journal:  Iran J Biotechnol       Date:  2019-04-20       Impact factor: 1.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.